EUVIMEDEUVIMED entdecken
Crossref

CCL28 ameliorates chronic liver damage associated with the recruitment of immunosuppressive IgA antibody-secreting cells in mice

Yuta Hara, Masamitsu Bando, Shunya Hosokawa, Yuki Ogo, Ryohei Okumura, Kazuhiko Matsuo, Takashi Nakayama

Life Sciences · 2026

DOI: 10.1016/j.lfs.2026.124615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Yuta Hara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemotherapy, Kindai University Faculty of Pharmacy, Higashi-osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Immunoglobulin A, Chemokines, CC, Liver, Liver Cirrhosis. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Kindai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: CCL28 functions as a key chemoattractant for IgA antibody-secreting cells (IgA+ ASCs) and is crucial for maintaining mucosal immune defense. Recent research has revealed IgA+ ASCs with immunosuppressive activity in non-mucosal tissues under inflammatory conditions. Here, we explored the contribution of CCL28 to chronic liver damage caused by carbon tetrachloride (CCl4). MATERIALS AND METHODS: We administered CCl4 to wild-type and CCL28 knockout (CCL28 KO) mice to induce chronic liver damage. Liver damage, inflammation, fibrosis, and the expression of chemokines and immunosuppressive molecules were evaluated by histology, real-time PCR, ELISA, and flow cytometry. KEY FINDINGS: Chronic CCl4 treatment increased CCL28 expression in endothelial cells and macrophages of injured liver tissues. CCL28 KO mice exhibited higher serum ALT levels and more severe liver fibrosis than wild-type mice. They also showed diminished numbers of IgA+ ASCs in the livers. Liver-infiltrating IgA+ ASCs highly expressed the immunosuppressive molecules IL-10 and FasL, together with the CCL28 receptor CCR10. Furthermore, activated hepatic stellate cells (HSCs), which primarily produce extracellular matrix proteins, were increased in the livers of CCL28 KO mice, while apoptotic HSCs were decreased. In vitro, B220+ cells containing immunosuppressive IgA+ ASCs enhanced HSC cytotoxicity, and this effect was attenuated by anti-FasL antibody. Consistent with these findings, anti-IL-10 receptor and anti-FasL antibody treatment exacerbated chronic liver damage and fibrosis in vivo. SIGNIFICANCE: These results demonstrate that CCL28 contributes to liver protection against chronic damage in association with the selective infiltration of immunosuppressive IgA+ ASCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin AChemokines, CCLiverLiver CirrhosisAnimalsMiceMice, KnockoutCarbon TetrachlorideInterleukin-10Fas Ligand ProteinMice, Inbred C57BLMaleReceptors, CCR10Hepatic Stellate CellsChronic Disease

Stichwörter der Autor:innen

Antibody-secreting cellsCCL28CCR10FasLIL-10IgA

Substanzen

Immunoglobulin AChemokines, CCCcl28 protein, mouseCarbon TetrachlorideInterleukin-10Fas Ligand ProteinReceptors, CCR10Ccr10 protein, mouseFasl protein, mouseIL10 protein, mouse

Autor:innen und Institutionen

  • Division of Chemotherapy, Kindai University Faculty of Pharmacy, Higashi-osaka, Osaka, Japan.
  • Division of Chemotherapy, Kindai University Faculty of Pharmacy, Higashi-osaka, Osaka, Japan. Electronic address: nakayama@phar.kindai.ac.jp.

Förderung

  • Kindai University

Zitieren

APA

Hara, Y., Bando, M., Hosokawa, S., Ogo, Y., Okumura, R., Matsuo, K., & Nakayama, T. (2026). CCL28 ameliorates chronic liver damage associated with the recruitment of immunosuppressive IgA antibody-secreting cells in mice. Life Sciences. https://doi.org/10.1016/j.lfs.2026.124615

Vancouver

Hara Y, Bando M, Hosokawa S, Ogo Y, Okumura R, Matsuo K, et al. CCL28 ameliorates chronic liver damage associated with the recruitment of immunosuppressive IgA antibody-secreting cells in mice. Life Sciences. 2026. doi:10.1016/j.lfs.2026.124615

BibTeX
@article{Hara2026,
  author = {Hara, Yuta and Bando, Masamitsu and Hosokawa, Shunya and Ogo, Yuki and Okumura, Ryohei and Matsuo, Kazuhiko and Nakayama, Takashi},
  title = {CCL28 ameliorates chronic liver damage associated with the recruitment of immunosuppressive IgA antibody-secreting cells in mice},
  journal = {Life Sciences},
  year = {2026},
  doi = {10.1016/j.lfs.2026.124615}
}
Kostenlos starten →